SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001206774-07-000697
Filing Date
2007-03-16
Accepted
2007-03-16 17:16:08
Documents
9
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT avigen_10k.htm 10-K 1406223
2 GRAPHIC avigen_10k2x4x1.jpg GRAPHIC 45473
3 OFFER LETTER WITH DR. STEPHEN DILLY exhibit10-63.htm EX-10.63 7959
4 OFFER LETTER WITH DR. JAN OHRSTROM exhibit10-64.htm EX-10.64 7799
5 CONSENT OF ODENBERG, ULLAKKO, MURANISHI & CO. LLP exhibit23-1.htm EX-23.1 1880
6 CONSENT OF ERNST & YOUNG LLP exhibit23-2.htm EX-23.2 1635
7 CEO CERTIFICATION REQUIRED BY RULE 13A-14(A) exhibit31-1.htm EX-31.1 7585
8 CFO CERTIFICATION REQUIRED BY RULE 13A-14(A) exhibit31-2.htm EX-31.2 7578
9 CERTIFICATION REQUIRED BY RULE 13A-14(B) exhibit32-1.htm EX-32.1 3397
  Complete submission text file 0001206774-07-000697.txt   1508268
Mailing Address 1301 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1301 HARBOR BAY PARKWAY . ALAMEDA CA 94502 5107487150
AVIGEN INC \DE (Filer) CIK: 0000932903 (see all company filings)

IRS No.: 133647119 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-28272 | Film No.: 07701152
SIC: 2835 In Vitro & In Vivo Diagnostic Substances